Prothena reported $-80960000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
ALKERMES USD 104.84M 79.35M Jun/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amgen USD 1.57B 405M Jun/2025
Biogen USD 744M 432.8M Jun/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
Exelixis USD 230.42M 24.72M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
MacroGenics USD -36150000 21.67M Jun/2025
Neurocrine Biosciences USD 159.5M 144.8M Jun/2025
Prothena USD -80960000 21.46M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Ultragenyx Pharmaceutical USD -114004000 35.77M Jun/2025
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025